CAR-T

Caribou Biosciences halts off-the-shelf CRISPR CAR-T programs for lymphoma and myeloma after failing to fund Phase 3… Medical Daily20:18Biotechnology Nobel Prizes CRISPR/Gene Editing

CAR-T specialist Caribou culls pipeline and seeks exit deal Pharmaceutical Technology17:49Biotechnology Nobel Prizes CRISPR/Gene Editing

Yonsei's L1CAM-targeted CAR-T eliminates ovarian tumors in preclinical study Korea Biomedical Review02:49Ovarian Cancer Cancer Treatment Cancer

In vivo CAR-T therapy transforms customized treatments into universal medicines News-Medical.Net15:16Ovarian Cancer Cancer Treatment Cancer

Bispecific antibodies, CAR-T therapy improve outcomes in follicular lymphoma: expert Korea Biomedical Review08:45Cancer Cancer Treatment Blood Cancer

Older patients with MCL less often reach CAR-T after covalent btki Rare Disease Advisor21:27Blood Cancer Science

Experts flag affordability, access gaps in advanced blood cancer treatment The Statesman15:05T-Cells India Global Health

Promising results with anti-BCMA/GPRC5D CAR-T in rrmm with extraosseous emd Hematology Advisor15:23T-Cells Science

CAR-T therapy shows durable benefits in myasthenia gravis Medpage Today15:51T-Cells

Link Cell Therapies expands logic-gated CAR-T therapy clinical delivery, boosts executive team, … China Money Network22:31Link Cell Therapies

Study identifies why some patients develop severe intestinal inflammation after CAR-T therapy ecancer14:41T-Cells Cancer Treatment Science

Lupus patients stopped every immunosuppressant after one off-the-shelf CAR-T dose in small trial, but therapy remains… Medical Daily17:14Science

Latest News

In the last 15 minutes

Legend Biotech Wins FDA Clearance For In Vivo car-T Therapy LB2501; Stock Up RTT News15:37

In the last 8 hours

Bispecific antibodies, CAR-T therapy improve outcomes in follicular lymphoma: expert Korea Biomedical Review08:45

In the last 7 days

Anixa Biosciences' Ovarian Cancer car-T Therapy Inventor to Deliver Keynote at Ovarian Cancer… PR Newswire (Press Release)13:44 13-Oct-26

Experts flag affordability, access gaps in advanced blood cancer treatment The Statesman15:05 12-Oct-26

T-maximum's B7-H3-Targeted Allogeneic car-T MT027 Receives FDA Clearance for Phase 2 Study in… PR Newswire (Press Release)11:52 12-Oct-26

Caribou Biosciences Halts Off-the-Shelf CRISPR CAR-T Programs for Lymphoma and Myeloma After Failing to Fund Phase 3… Medical Daily20:18 10-Oct-26

Meeting On The Mesa: Execs Stress Importance Of Durability In Autoimmune CAR-T Scrip Pharma Intelligence22:08 9-Oct-26

CellFiber Opens US Subsidiary in Philadelphia to Accelerate Scalable Manufacturing of iPSC,… PR Newswire (Press Release)13:57 9-Oct-26

Airport handling and visibility emerge as CAR-T logistics gaps The Stat Trade Times13:42 9-Oct-26

Meeting On The Mesa: In Vivo CAR-T Could Expand Access, But Caution Needed Scrip Pharma Intelligence22:42 8-Oct-26

Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate BioPharma Dive09:05 8-Oct-26

Yonsei's L1CAM-targeted CAR-T eliminates ovarian tumors in preclinical study Korea Biomedical Review02:49 8-Oct-26

In the last month

CAR-T specialist Caribou culls pipeline and seeks exit deal Pharmaceutical Technology17:49 7-Oct-26

Caribou Biosciences Stock Falls 43% RTT News16:04 7-Oct-26

Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down STAT09:41 7-Oct-26

Anixa Biosciences Reports Stable Disease In Ovarian Cancer car-T Trial RTT News15:21 5-Oct-26

Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer… PR Newswire (Press Release)13:20 5-Oct-26

BlueWhale Bio Highlights Continued Progress Across Cell Therapy Platform and Operations PR Newswire (Press Release)13:04 5-Oct-26

TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (Dor)… PR Newswire (Press Release)12:50 5-Oct-26

Cross-hospital effort, late Samsung chair’s donation open CAR-T therapy to child with leukemia Korea JoongAng Daily08:25 5-Oct-26

Breathe Forward Foundation Launches National Cancer Research Mission with Inaugural "Glow for… PRWeb (Press Release)18:39 3-Oct-26

Anixa Treats Second Patient At Highest Dose In Ovarian Cancer car-T Study RTT News17:22 1-Oct-26

Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian… PR Newswire (Press Release)13:35 1-Oct-26

Chimeric antigen receptor T (car-T) cell therapy in non-oncological diseases Nature.com00:30 1-Oct-26

Novel CAR-T therapy for hard-to-treat multiple myeloma shows promising safety and durable responses Newswise (Press Release)22:04 30-Sept-26

Lupus Patients Stopped Every Immunosuppressant After One Off-the-Shelf CAR-T Dose in Small Trial, but Therapy Remains… Medical Daily17:14 30-Sept-26

CAR-T Therapy Shows Durable Benefits in Myasthenia Gravis Medpage Today15:51 30-Sept-26

Promising Results With Anti-BCMA/GPRC5D CAR-T in RRMM With Extraosseous EMD Hematology Advisor15:23 30-Sept-26

Laverock Therapeutics announces in vivo programs in oncology and genetic medicine News-Medical.Net12:56 30-Sept-26

Seasoned Biotech Finance Executive Florian Schmid Appointed CFO of T-CURX to Support Next Phase of Growth Biotech, B3C newswire08:02 30-Sept-26

Older Patients With MCL Less Often Reach CAR-T After Covalent BTKi Rare Disease Advisor21:27 29-Sept-26

Enhancing CAR-T Therapy: From Cancer to Autoimmune Diseases Newswise (Press Release)18:19 29-Sept-26

Link Cell Therapies Expands Logic-Gated car-T Therapy Clinical Delivery, Boosts Executive Team, … China Money Network22:31 28-Sept-26

Link Cell Therapies Initiates Clinical Dosing with Logic-Gated car-T Therapy, Expands Executive … PR Newswire (Press Release)12:06 28-Sept-26

Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly Adi-001) Study… Business Wire (Press Release)11:46 28-Sept-26

China now leads the world in trials for next-gen car-T therapies Nature.com08:06 28-Sept-26

2026 IMS | Iaso Bio Presented First-in-Human Data of Bcma-Targeted In Vivo car-T Cell Therapy… PR Newswire (Press Release)04:07 27-Sept-26

Adicet Bio to Host Webcast to Present Prula-cel (formerly Adi-001) Clinical Data in Patients… Business Wire (Press Release)21:02 25-Sept-26

2026 IMS | Iaso Bio Presents First-in-Human Phase 1 Data of RD140, a Fully Human Bcma/GPRC5D… PR Newswire (Press Release)16:33 25-Sept-26

2026 IMS | Updated Fumanba-1 Analysis of Iaso Bio's Fucaso Reveals That In Vivo Durable… PR Newswire (Press Release)15:55 25-Sept-26

In vivo CAR-T therapy transforms customized treatments into universal medicines News-Medical.Net15:16 25-Sept-26

Kyverna’s stiff-person syndrome trial shows one-year durability Clinical Trials Arena15:02 25-Sept-26

Study identifies why some patients develop severe intestinal inflammation after CAR-T therapy ecancer14:41 25-Sept-26

A behind-the-scenes look at how Johnson & Johnson manufactures and delivers CAR-T cell therapy for multiple myeloma Johnson & Johnson (Press Release)12:00 25-Sept-26

Mount Sinai Study Identifies Why Some Patients Develop Severe Intestinal Inflammation After CAR-T Therapy Newswise (Press Release)19:00 24-Sept-26

Kyverna builds case for CAR-T in stiff person syndrome pharmaphorum13:08 24-Sept-26

One-Year Benefits Sustain Momentum For Kyverna's Autoimmune car-T Therapy; Stock Up RTT News13:00 24-Sept-26

Allotera Therapeutics Announces Opening of Minimal Residual Disease Cohort in the Pivotal… Business Wire (Press Release)14:06 23-Sept-26

Study shows reprogramming thyroid tumours may improve CAR-T cell therapy ecancer10:58 22-Sept-26

UCLA team engineers ‘triple-threat’ immune cells to fight plaque buildup behind heart attacks, strokes Newswise (Press Release)21:25 21-Sept-26

The Next Chapter of B7-H3: From Systemic Disease to the Brain PR Newswire (Press Release)12:50 21-Sept-26

Dad given 'second chance at life' after innovative cancer treatment STV12:45 19-Sept-26

Study shows reprogramming thyroid tumors may improve CAR-T cell therapy Newswise (Press Release)22:45 17-Sept-26

Breakthrough cancer treatment in Glasgow gives patient ‘second chance at life’ Glasgow Evening Times12:04 17-Sept-26

Biotech Stocks See Fresh Catalysts: Tempest, DataMEDS, NeurAxis & Maia RTT News20:06 16-Sept-26

Medisights Pioneers New Standard: AI Agents Capture Unprecedented Near Real-Time Market… PR Newswire (Press Release)19:24 16-Sept-26

Tempest Therapeutics (Tpst) Stock Surges Wednesday: What's Driving the Action? Benzinga16:37 16-Sept-26

Prestigious award for biotech company based on UCLH and UCL research UCLH NHS Foundation Trust (Press Release)12:07 16-Sept-26

Cellares and GenomeFrontier Therapeutics Partner to Evaluate Automated Manufacturing for… Business Wire (Press Release)12:05 16-Sept-26

Iaso Bio's CD20-Targeted In Vivo car-T Therapy IASO208 Receives FDA Ind Clearance PR Newswire (Press Release)10:52 16-Sept-26

Senlang/Tempest Option Marks China’s First Global Deal For In Vivo CAR-T Scrip Pharma Intelligence09:00 16-Sept-26

Consensus Recommendations Published for CAR-T Therapy in Adult ALL Hematology Advisor14:32 15-Sept-26

Allo-HCT After CAR-T Therapy Improves Outcomes for Patients With R/R B-ALL Hematology Advisor14:32 15-Sept-26

view more headlines

15 Oct 15:37

About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.